今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
附件
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1271次   下载 1657 本文二维码信息
码上扫一扫!
分享到: 微信 更多
苦参素联用单磷酸阿糖腺苷治疗慢性乙型肝炎的临床研究
谢碧红
江苏省南京市第二医院, 南京, 210003
摘要:
[目的]探讨苦参素联用单磷酸阿糖腺苷治疗慢性乙型肝炎的临床效果。[方法]将152例慢性乙型肝炎随机分成联合治疗组、苦参素组、单磷酸阿糖腺苷组进行对照观察。[结果]联合治疗组在HBeAg、HBV-DNA阴转方向较单用苦参素或单磷酸阿糖腺苷效果好,治疗6个月和12个月其总有效率三组无明显差异。[结论]联合用药较单一用药效果为佳。
关键词:  慢性乙型肝炎  苦参素  单磷酸阿糖腺苷  联合用药
DOI:10.11656/j.issn.1672-1519.2003.04.16
分类号:
基金项目:
Clinical research on chronic hepatitis B treated by kurarinone combined with arabinosyladenosine monophosphate (Ara-Amp)
XIE Bi-hong
Nanjing Second Hospital, Nanjing 210003, China
Abstract:
[Objective] To discuss the effect of kurarinone combined with arabinosyladenosine monophosphate (Ara-Amp) on chronic hepatitis B. [Methods] One hundred and fifty-two patients were divided into combination group, kurarinone group and Ara-Amp group. [Result] The negative turning of HbeAg, HBV-DNA in combination treatment group was superior to that in other two groups. There was no marked diffecence of the overall effective rate between these 3 groups 6 months and 12 months after treatment. [Conclusion] The combination treatment is more effective than the treatment with single medicine.
Key words:  chronic Hepatitis B  kurarinone  Ara-Amp  combination treatment
关注公众号二维码